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Increasing prevalence of hypertension in Hong Kong Cardiovascular Risk Factor Prevalence  
Study: role of general and central obesity 
BMY Cheung, KL Ong, AWK Tso, TH Lam, KSL Lam
Department of Medicine, The University of Hong Kong, Hong Kong
introduction: General obesity and central obesity are well-known risk factors of hypertension. We investigated the 
change in the prevalence of hypertension in the population-based prospective Hong Kong Cardiovascular Risk Factor 
Prevalence Study (CRISPS) and the relationship of change in blood pressure with change in body mass index (BMI) and 
waist circumference over a follow-up period of 11.9 years.
Methods: A total of 2888, 1942 and 1798 subjects in CRISPS-1 (1995-1996), CRISPS-2 (2000-2004) and CRISPS-3 
(2005-2008) were included in this analysis respectively. Hypertension was defined as blood pressure ≥140/90 mm 
Hg or taking anti-hypertensive medication. General obesity was defined as BMI ≥27.5 kg/m2 and central obesity was 
defined as waist circumference ≥90 cm in men or ≥80 cm in women.
Results: The prevalence of hypertension increased from 18.1% to 39.4% (P<0.001 after adjusting for age and sex). 
The prevalence of central obesity increased from 25.4% to 41.4%, but that of general obesity decreased from 16.8% 
to 14.8% (both P<0.001 after adjusting for age and sex). Among 1347 subjects who did not take any anti-hypertensive 
medication at both CRISPS-1 and CRISPS-3, the change in waist circumference, but not that in BMI, was associated 
with the changes in both systolic and diastolic blood pressures (beta=0.087, P=0.015 and beta=0.122, P<0.001 
respectively).
Conclusions: The increase in prevalence of hypertension might be explained by the increase in central obesity. Our 
findings further confirm the importance of waist circumference in this population; calculating the BMI alone may give 
a false sense of security. 
Acknowledgement: This study was funded by Hong Kong Research Grant Council grants (HKU7229/01M and HKU7626/07M) 
and the Sun Chieh Yeh Heart Foundation.
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Ubiquitination is indispensible for the insulin-sensitising activity of the adaptor protein  
APPL1
KKY Cheng1, KSL Lam1, Y Wang1, WD Zhu1, A Xu1,2 
1Department of Medicine, The University of Hong Kong, Hong Kong
2Department of Pharmacology, The University of Hong Kong, Hong Kong
Background: Insulin inhibits hepatic glucose production through activation of the protein kinase Akt. Our previous 
work has identified the multi-domain adaptor protein APPL1 as a positive modulator of insulin-evoked Akt activation 
in hepatocytes. However, the detailed mechanisms remain elusive. This study aimed to address the role of post-
translational modification in APPL1-mediated potentiating effects on hepatic actions of insulin. 
Methods: Rat hepatocytes were infected with adenovirus encoding luciferase control or FLAG-tagged APPL1 together 
with HA-tagged ubiquitin, followed by serum starvation and stimulation with insulin (10 nM). Total cell lysate was 
subjected to immunoprecipitation, Western blot analysis, and real-time quantitative PCR analysis. Ubiquitination of 
APPL1 was detected by Western blot analysis. Ultracentrifugation was employed to separate the hepatocytes into 
cytosolic and plasma membrane fractions.
Results and Conclusion: In rat hepatocytes, APPL1 undergoes ubiquitination upon insulin stimulation in a time-
dependent manner. APPL1 ubiquitination is lysine 63-linked but not lysine 48-linked, indicating that this post-
translational modification may regulate its cellular localisation and functions, but is not responsible for proteasomal 
degradation. Our mutagenesis experiment identified that APPL1 residue lysine 160 is the site for its ubiquitination. 
Mutation of lysine 160 to arginine abolishes the potentiating effects of APPL1 on insulin sensitivity. Further analysis 
reveals that an E3 ubiquitin ligase, tumour necrosis factor receptor associated factor (TRAF6), is responsible for 
ubiquitination of APPL1. This E3 ligase is associated with APPL1 upon insulin treatment. Over-expression of TRAF6 
further enhances insulin-stimulated APPL1 ubiquitination. Moreover, knockdown of TRAF6 expression attenuates 
insulin-mediated translocation of APPL1 from cytosol to cellular membrane, which in turn inhibits the potentiating 
actions of APPL1 on insulin signalling. Taken together, these results support the notion that APPL1 ubiquitination is a 
vital step for hepatic functions of insulin through modulating the intracellular trafficking of Akt.
Acknowledgement: This work was supported by General Research Fund (HKU 779707M).
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